STAAR Surgical Company provided earnings guidance for the fourth quarter and full year ending December 31, 2021and full year of 2022. For the quarter, the company expects total net sales to be approximately $59 million and GAAP earnings per share is expected to be approximately $0.10.

For the full year 2021, the company expects net sales to be approximately $230 million and GAAP earnings per share to be approximately $0.50.

For the full year 2022, The company expects net sales will grow to
approximately $295 million subject to no unforeseen impact from Covid on the business.